---
layout: phenotype
title: Type 2 Diabetes
phenotype_id: Z6mT6cKpY3zeTymmmCYCSL
name: Type 2 Diabetes
type: Disease or Syndrome
group: Endocrine
sources: 
    - clinicalcodes
data_sources:
    - Clinical Practice Research Datalink GOLD
clinical_terminologies:
    - Read Version 2
validation:
codelists: Joseph_Type2Diabetesread_Z6mT6cKpY3zeTymmmCYCSL_Read2.csv
valid_event_data_range: 01/01/1998 - 10/01/2012
sex:
    - Female
    - Male
author:
    - Rebecca M Joseph
    - Mohammad Movahedi
    - William G Dixon
    - Deborah P M Symmons    
publications:
    - Rebecca M Joseph, Mohammad Movahedi, William G Dixon, Deborah P M Symmons, Smoking-Related Mortality in Patients With Early Rheumatoid Arthritis: A Retrospective Cohort Study Using the Clinical Practice Research Datalink. Authritis Care and Research, 68(11), 1598-1606, 2016.
status: FINAL
date: 2016-10-06
modified_date: 2016-10-06
version: Revision 1
---

### Primary Care

{% include csv.html csvdata=site.data.codelists.Joseph_Type2Diabetesread_Z6mT6cKpY3zeTymmmCYCSL_Read2 %}

### Implementation

Objective:
To investigate the association between smoking status and smoking cessation with mortality in patients with rheumatoid arthritis (RA).

Methods:
An incident cohort of patients with RA was identified using the Clinical Practice Research Datalink, a database of UK primary care electronic medical records. Time-varying smoking status, years of cessation, and amount smoked were determined frompatientsâ€™medical records. The date and underlying cause of deathwere identified by linkagewith Office for National Statistics records. The associations between smoking status and smoking cessation with all-cause and causespecific mortality (circulatory disease, all cancers, lung cancer, respiratory disease, and respiratory infection) were investigated using adjusted Cox (all-causemortality) and Fine-Gray (cause-specificmortality) regression. 

Results: 
The cohort comprised 5,677 patients (median age 61.4 years, 68% women), with 40% as never smokers, 34% former smokers, and 26% current smokers at baseline. Compared to never smoking, current smokingwas associated with an increased risk of all-causemortality (hazard ratio 1.98 [95% confidence interval (95% CI) 1.56, 2.53]), andmortality due to circulatory disease (subdistribution hazard ratio [SHR] 1.96 [95% CI 1.33, 2.90]) and lung cancer (SHR 23.2 [95% CI 5.15, 105]). Each year of smoking cessation was associated with a decreased risk of all-cause mortality (former heavy smokers SHR 0.85 [95% CI 0.77, 0.94], former light smokers SHR 0.90 [95%CI 0.84, 0.97]).

Conclusion: 
Current smoking is associated with an increased risk of all-cause, cardiovascular, and lung cancermortality in patientswith RA. Each year of cessation is associated with a reduced risk of all-causemortality. This information may prove helpful in smoking cessation programs for patients with RA.

### Publications

<pre>
Rebecca M Joseph, Mohammad Movahedi, William G Dixon, Deborah P M Symmons, Smoking-Related Mortality in Patients With Early Rheumatoid Arthritis: A Retrospective Cohort Study Using the Clinical Practice Research Datalink. Authritis Care and Research, 68(11), 1598-1606, 2016.
</pre>

